BCX4430 er et antiviralt middel utviklet av BioCryst Pharmaceuticals med finansiering fra NIAID, opprinnelig ment for behandsling av hepatitt C, men senere utviklet for potensiell behandling av dødelige filovirusinfeksjoner som ebolafeber og marburgfeber.
It is also appropriate to provide grants to the three legal support structures, the exclusive aim of which is to provide administrative support to the Committee of European Securities Regulators, established by Commission Decision #/#/EC, the Committee of European Banking Supervisors, established by Commission Decision #/#/EC and the Committee of European Insurance and Pension Supervisors, established by Commission Decision #/#/EC (together, the Committees of Supervisors), for carrying out their mandates and projects relating to supervisory convergence, in particular training of staff of national supervisory authorities and management of information technology projectsWikiMatrix WikiMatrix